Table 6.
Multivariate linear regression analysis for SDU-P (planned procedures) as the dependent variable with statistically significant independent parameters including collinearity statistics (statistically significant parameters are in bold).
| Parameter | B | Std. Error | p Value | Exp(B) and 95% Wald Confidence Interval for | Collinearity Statistics | |
|---|---|---|---|---|---|---|
| Tolerance | VIF | |||||
| (Intercept) | 6.30 | 1.43 | <0.001 | |||
| Age (years) | 0.17 | 0.004 | <0.001 | 1.19 (1.18–1.20) | 0.606 | 1.650 |
| Sex: male vs. female | 0.06 | 0.04 | 0.116 | 1.07 (0.98–1.16) | 0.961 | 1.041 |
| Socio-economic status (SES)—low vs. high | 1.32 | 0.09 | <0.001 | 3.76 (3.12–4.54) | 0.940 | 1.064 |
| Socio-economic status (SES)—medium vs. high | 0.61 | 0.03 | <0.001 | 1.85 (1.71–1.99) | 0.958 | 1.044 |
| The locality of residence: urban non-Jewish vs. urban Jewish | −0.35 | 0.05 | <0.001 | 0.70 (0.63–0.78) | 0.974 | 1.026 |
| The locality of residence: rural vs. urban Jewish | 0.57 | 0.46 | 0.215 | 1.77 (0.71–4.41) | 0.978 | 1.022 |
| Birth country: Western Europe vs. native Israeli | 0.81 | 0.06 | <0.001 | 2.26 (1.97–2.58) | 0.980 | 1.020 |
| Birth country: Eastern Europe and FSU vs. native Israeli | 1.23 | 0.16 | <0.001 | 3.43 (2.52–4.67) | 0.994 | 1.006 |
| Birth country: Asia vs. native Israeli | −1.12 | 0.30 | 0.887 | 0.88 (0.48–1.62) | 0.998 | 1.002 |
| Birth country: Ethiopia vs. native Israeli | 0.66 | 0.14 | <0.001 | 1.93 (1.45–2.57) | 0.992 | 1.008 |
| Birth country: Africa vs. native Israeli | 0.23 | 0.37 | 0.531 | 1.26 (0.60–2.64) | 0.997 | 1.003 |
| Birth country: North America vs. native Israeli | −0.64 | 0.13 | <0.001 | 0.52 (0.40–0.68) | 0.994 | 1.006 |
| Birth Country: South America vs. native Israeli | 0.22 | 0.21 | 0.318 | 1.24 (0.81–1.90) | 0.998 | 1.002 |
| Brushing teeth less than once a day | 0.46 | 0.05 | <0.001 | 1.58 (1.42–1.77) | 0.986 | 1.014 |
| Consumption of sweetened beverages | 0.27 | 0.03 | <0.001 | 1.31 (1.22–1.41) | 0.986 | 1.014 |
| Smoking | 0.30 | 0.09 | 0.002 | 1.36 (1.12–1.64) | 0.785 | 1.274 |
| Hypertension | 0.08 | 0.12 | 0.504 | 1.08 (0.85–1.38) | 0.918 | 1.089 |
| Diabetes mellitus | 0.44 | 0.37 | 0.239 | 1.56 (0.74–3.27) | 0.946 | 1.058 |
| Impaired glucose tolerance (IGT) | 2.00 | 0.69 | 0.004 | 7.40 (1.91–28.57) | 0.974 | 1.027 |
| Hyperlipidemia | 0.05 | 0.23 | 0.806 | 1.06 (0.66–1.68) | 0.962 | 1.040 |
| Obesity | 0.16 | 0.09 | 0.086 | 1.18 (0.98–1.43) | 0.706 | 1.416 |
| Cardiovascular disease | 0.001 | 0.12 | 0.992 | 1.00 (0.79–1.26) | 0.939 | 1.065 |
| Fatty liver | 0.60 | 0.22 | 0.008 | 1.82 (1.17–2.84) | 0.904 | 1.106 |
| Obstructive sleep apnea (OSA) | 1.61 | 0.37 | <0.001 | 5.05 (2.40–10.63) | 0.974 | 1.027 |
| Transient ischemic attack (TIA) | 0.93 | 0.68 | 0.157 | 2.61 (0.69–9.90) | 0.972 | 1.029 |
| Stroke | 0.16 | 0.68 | 0.809 | 1.17 (0.31–4.47) | 0.971 | 1.030 |
| Deep vein thrombosis (DVT) | 1.72 | 0.66 | 0.009 | 5.61 (1.53–20.83) | 0.972 | 1.029 |